Cerebrovascular, Stroke and Endovascular
Stroke is the number one cause of major disability in our country and the 4th leading cause of mortality today. The URMC Stroke, Cerebrovascular and Endovascular program aims to provide our area with the most comprehensive stroke care possible to ensure patients don’t become just another statistic. We understand not just the physical disability from stroke but also the economic and psychosocial burden on our community. Our diligent team at the URMC Stroke, Cerebrovascular & Endovascular program has successfully achieved the highest rates of acute intervention and secondary stroke prevention possible for stroke in the region.
Why Choose URMC Neurosurgery?
The URMC Stroke, Cerebrovascular and Endovascular program offers world-class treatment and prevention of stroke, is the region’s only Comprehensive Stroke Center and has the area’s only dedicated Neuromedicine Intensive Care Unit.
Our nationally recognized, highly trained stroke and neuro-critical care team and state-of-the-art neuro-imaging capabilities are truly a one of a kind offering in the region in caring for all types of stroke and cerebrovascular diseases.
URMC has a state-of-the-art Endovascular stroke suite that enables our team to provide you with the most advanced interventions for stroke and cerebrovascular diseases.
Our stroke protocol incorporates an extended panel of blood tests and the most innovative imaging studies including multi-modal CT scanning – new technologies that enable us to expand the time window to stop the devastating effects of stroke to 8 hours and beyond.
Our team uses a revolutionary procedure endovascular thrombectomy in addition to routine medical therapy to reach reach clots in the brain directly and gently remove them, restoring blood flow and dramatically reducing effects of stroke.
The URMC Stroke, Cerebrovascular and Endovascular program combines established methods with the latest medical and surgical techniques like carotid and intracranial stents to help prevent strokes in patients most at risk for having one.
A state of the art Endovascular Stroke suite and our multidisciplinary team of neurosurgeons provide the most advanced care in the region.
Babak S. Jahromi, M.D. Ph.D.
Dr. Jahromi is the Surgical Director of the URMC Stroke and Cerebrovascular Center and an Assistant Professor of Neurosurgery and Imaging Sciences. Dr. Jahromi holds a double fellowship in endovascular and cerebrovascular surgery. He has received the highest awards for neurological research in Canada, from the University of Toronto, the Royal College of Physicians & Surgeons of Canada, and the Canadian Neurological Society.
Robert Replogle M.D.
Dr. Robert E. Replogle serves as a URMC Assistant Professor of Neurosurgery and Imaging Sciences. Dr. Replogle completed a combined fellowship in neuroendovascular and operative cerebrovascular surgery at the University of Texas Southwestern and served on staff at that institution. Dr. Replogle is also very active in the field of minimally invasive spine surgery, pioneering a numerous techniques, and has been active in teaching minimally invasive spine courses at both the national and international level.
Amrendra S. Miranpuri, M.D.
Cindy Zink, PA
Kim Page, RN, NP, MS
Sharon Mansfield, NP
Conditions We Treat
Below is a listing of the conditions treated by the Stroke and Endovascular Therapy Center. Please contact us, or click on a condition to read more about the condition in a new window.
Research in the Center for Stroke and Endovascular Therapy focuses around gaining insight into the possible use of multi-modal CT scanning for predicting stroke outcomes and around the health services perspective on current practice for stroke treatment and its prevention in the United States. Some of the projects at the center include:
Cost Effectiveness of multimodal CT for evaluating Acute Stroke
Multimodal CT, including non-contrast CT (NCCT), CT with contrast, CT angiography (CTA), and perfusion CT (CTP), is increasingly used in acute stroke patients to identify candidates for endovascular therapy. Our goal in this study is to explore the cost-effectiveness of multimodal CT as a diagnostic test. Our findings so far indicate that Multimodal CT appears to be a cost-saving screening tool over the short term.
We are in the process of collecting additional data regarding clinical outcomes following multimodal CT-guided intra-arterial treatment to adjudge the long-term cost effectiveness of this modality. Learn more.
Utility of Carotid Artery Stenting in Asymptomatic Carotid Stenosis
This research is focused on analyzing outcomes of patients undergoing Carotid Artery Stenting in a representative sample of countrywide inpatients. Our initial research has shown, that Carotid Artery Stenting as practiced currently in the country, is independently associated with increased in-hospital stroke/death in patients ≥ 80 years of age.
We are in the process of analyzing outcomes in other age groups. This research highlights the importance of auditing procedures nationally to formulate definitive guidelines for the use of invasive procedures. Learn more.
Optimal Patient Selection and Imaging for Carotid Endarterectomy
This research focuses on how to best select patients who will benefit from carotid surgery or stenting to prevent future stroke, and the role of CT angiography in carotid endarterectomy. Learn more.
Perfusion CT scanning in Acute Ischemic Stroke
This research study is focused on analyzing variables availed by doing perfusion CT scanning in patients of acute ischemic stroke and their association with functional outcomes in patients. This research also looks at using the variables to predict important complications of therapy in stroke like Hemorrhagic Transformation and re-current stroke. This research will also look at the feasibility of introducing Perfusion CT scanning in regular Acute Ischemic Stroke screening protocols. Learn more.
New therapies for treating Vasospasm after Sub Arachnoid Hemorrhage
Sub-arachnoid hemorrhage (SAH) is a form of stroke that comprises 1-7% of patients. It can lead to death or severe disability even when recognized and treated at an early stage. More than 50% of patients die after suffering an SAH. The most common complication of SAH is the vasospasm that follows it. This research is looking at new invasive and non-invasive modalities to address this common complication to improve outcomes in patients.